NO880179D0 - POLYMER COMPLEXES, PROCEDURE FOR THE PREPARATION OF THESE, AND PHARMACEUTICAL AGENTS CONTAINING THESE. - Google Patents

POLYMER COMPLEXES, PROCEDURE FOR THE PREPARATION OF THESE, AND PHARMACEUTICAL AGENTS CONTAINING THESE.

Info

Publication number
NO880179D0
NO880179D0 NO880179A NO880179A NO880179D0 NO 880179 D0 NO880179 D0 NO 880179D0 NO 880179 A NO880179 A NO 880179A NO 880179 A NO880179 A NO 880179A NO 880179 D0 NO880179 D0 NO 880179D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
pharmaceutical agents
agents containing
polymer complexes
Prior art date
Application number
NO880179A
Other languages
Norwegian (no)
Other versions
NO880179L (en
Inventor
Heinz Gries
Julius Deutsch
Erich Klieger
Ulrich Niedballa
Franz-Josef Renneke
Juergen Conrad
Wolfgang Muetzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO880179D0 publication Critical patent/NO880179D0/en
Publication of NO880179L publication Critical patent/NO880179L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
NO880179A 1987-01-19 1988-01-18 POLYMER COMPLEX, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL AGENTS CONTAINING THESE. NO880179L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873701665 DE3701665A1 (en) 1987-01-19 1987-01-19 POLYMER COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Publications (2)

Publication Number Publication Date
NO880179D0 true NO880179D0 (en) 1988-01-18
NO880179L NO880179L (en) 1988-07-20

Family

ID=6319226

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880179A NO880179L (en) 1987-01-19 1988-01-18 POLYMER COMPLEX, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL AGENTS CONTAINING THESE.

Country Status (10)

Country Link
EP (1) EP0277088A2 (en)
JP (1) JPS6454028A (en)
AU (1) AU1064988A (en)
DE (1) DE3701665A1 (en)
DK (1) DK22688A (en)
IE (1) IE880127L (en)
IL (1) IL85139A0 (en)
NO (1) NO880179L (en)
PT (1) PT86572B (en)
ZA (1) ZA88342B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806795A1 (en) * 1988-02-29 1989-09-07 Schering Ag POLYMER-TIED COMPLEX IMAGERS, THEIR COMPLEXES AND CONJUGATES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THEM
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
FR2645862B1 (en) * 1989-04-18 1991-07-12 Esteve Labor Dr SUBSTITUTED ISOTHIAZOLO-PYRYDONE AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
US5384108A (en) * 1989-04-24 1995-01-24 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
DE3938992A1 (en) 1989-11-21 1991-05-23 Schering Ag Cascade polymer-bound complex formers, their complexes and conjugates, process for their preparation and pharmaceutical compositions containing them
DE4017439C2 (en) * 1990-05-30 1994-06-23 Deutsches Krebsforsch Polyether-substituted tumor agents
DE4039920A1 (en) * 1990-12-14 1992-06-17 Basf Ag NEW POLYETHYLENIMINE AND POLYVINYLAMINE DERIVATIVES, CARRIER MATERIALS COATED WITH THESE DERIVATIVES ON THE BASIS OF ALUMINUM AND THE USE THEREOF FOR THE PRODUCTION OF OFFSET PRINTING PLATES
JP2901787B2 (en) * 1991-07-15 1999-06-07 日本メジフィジックス株式会社 Nuclear magnetic resonance contrast agent
JP2894879B2 (en) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 Diagnostic contrast agent
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
WO1994008624A2 (en) * 1992-10-14 1994-04-28 Sterling Winthrop Inc. Therapeutic and diagnostic imaging compositions and methods
EP1419786A1 (en) 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITPD20030174A1 (en) * 2003-07-31 2003-10-29 Univ Padova POLYMERIC CONJUGATES FOR DIAGNOSTICS AND THERAPY
DE102005039154A1 (en) * 2005-08-17 2007-03-01 GÖPFERICH, Achim, Prof. Dr. Biodegradable polymers for the transport of nucleic acids into cells
MX2022014143A (en) 2020-05-12 2022-11-30 Basf Se Use of carboxymethylated polymer of lysines as dispersing agent and compositions comprising the same.

Also Published As

Publication number Publication date
ZA88342B (en) 1988-07-04
EP0277088A2 (en) 1988-08-03
JPS6454028A (en) 1989-03-01
IE880127L (en) 1988-07-19
PT86572B (en) 1991-12-31
PT86572A (en) 1988-02-01
DK22688A (en) 1988-07-20
NO880179L (en) 1988-07-20
DE3701665A1 (en) 1988-07-28
DK22688D0 (en) 1988-01-19
AU1064988A (en) 1988-07-21
IL85139A0 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
NO893896D0 (en) PHARMACEUTICAL FORMULATIONS AND PROCEDURES FOR PREPARING THESE.
DK467388A (en) QUINOLON AND NAPHTHYRIDINE DERIVATIVES, ANTIBACTERIAL AGENTS CONTAINING THESE AND PROCEDURES FOR PREPARING THEREOF
DK0489647T3 (en) N, O-sulfated heparosans, processes for their preparation, and drugs containing these compounds.
NO880179D0 (en) POLYMER COMPLEXES, PROCEDURE FOR THE PREPARATION OF THESE, AND PHARMACEUTICAL AGENTS CONTAINING THESE.
DK343388A (en) 2,2-DIMETHYLCHROMAN-3-OL DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF PHARMACEUTICAL AGENTS
NO880443L (en) N-HETEROCYCLIC-N- (4-PIPERIDYL) -AMIDS AND PHARMACEUTICAL PREPARATIONS AND PROCEDURES FOR USING SUCH COMPOUNDS.
DK219387D0 (en) AMINOTHIAZOL AND AMINOOXAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK431586D0 (en) BENZIMIDAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THE MEDICINAL PRODUCT CONTAINING THESE
DK276189A (en) POLYPEPTIME RELATIONSHIPS, PROCEDURES FOR PREPARING THOSE PHARMACEUTICAL AGENTS CONTAINING THESE
DK162221C (en) CINNOL COMPOUNDS, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THE COMPOUNDS
DK642588A (en) INDANDER DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
NO871844D0 (en) KNITTED SUBSTANCES AND PROCEDURES FOR PREPARING THESE.
PH24836A (en) Alkyl-substituted n-benzopyranyllactams,their use and pharmaceutical preparations based on these compounds
DE3867086D1 (en) BENZOTHIEPINO (5,4-C) PYRIDAZINE COMPOUNDS AND THEIR PHARMACEUTICAL EFFECTS.
DK396385A (en) 2,3-DIHYDRO-LH INDENDER DERIVATIVES, PROCEDURES FOR PREPARING IT AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE RELATIONSHIPS
NO892499L (en) 2,5,6,7-TETRANOR-4,8-INTER-M-PHENYL PGI2 DERIVATIVES, PROCEDURE FOR THE PREPARATION OF THESE, AND APPLICATION THEREOF.
DK340388A (en) AMINOCYCLOPENTYLETHYLETERS, PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
NO881713D0 (en) PROCEDURE FOR THE PREPARATION OF DI-T-BUTYLPHENYL-ALKYL AND BENZYLETHERS.
DK131188A (en) 3- (2-HALOGENALKYL) -1,4-OXATHIINES AND 2 (2-HALOGENALKYL) -1,4-DITHIINES, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE FOR THE TREATMENT OF LEUKAEMI AND TUMORS
NO880592D0 (en) HARDENABLE RESINTS, PROCEDURE FOR THE MANUFACTURE OF THESE AND APPLICATION OF THESE.
NO905520L (en) RIFAMYCIN DERIVATIVES AND PROCEDURES FOR THE PREPARATION OF THESE.
NO891986D0 (en) PROCEDURE FOR THE PREPARATION OF DIPHENYL SULPHIDS, DIPHENYL SULPHOXIDES AND DIPHENYL SULPHONES.
DK379287D0 (en) 1,3-PROPANDIAMINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
NO891987D0 (en) PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED PHENYLTIOANILINES, PHENYLSULPHINYLANILINES AND PHENYLSULPHONYLANILINES.
NO885058L (en) 6-OXOPROSTAGLANDIN-E-DERIVATIVES, PROCEDURES FOR THE PREPARATION OF THESE AND THEIR PHARMACEUTICAL USE.